[go: up one dir, main page]

GB201818152D0 - Molecular adjuvant - Google Patents

Molecular adjuvant

Info

Publication number
GB201818152D0
GB201818152D0 GBGB1818152.9A GB201818152A GB201818152D0 GB 201818152 D0 GB201818152 D0 GB 201818152D0 GB 201818152 A GB201818152 A GB 201818152A GB 201818152 D0 GB201818152 D0 GB 201818152D0
Authority
GB
United Kingdom
Prior art keywords
molecular adjuvant
adjuvant
molecular
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1818152.9A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ADC Therapeutics SA
MedImmune Ltd
Original Assignee
ADC Therapeutics SA
MedImmune Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ADC Therapeutics SA, MedImmune Ltd filed Critical ADC Therapeutics SA
Priority to GBGB1818152.9A priority Critical patent/GB201818152D0/en
Publication of GB201818152D0 publication Critical patent/GB201818152D0/en
Priority to EP19729452.3A priority patent/EP3796942A1/en
Priority to CA3098103A priority patent/CA3098103A1/en
Priority to EA202092296A priority patent/EA202092296A1/en
Priority to CN201980034789.3A priority patent/CN113286616A/en
Priority to JP2020564541A priority patent/JP2021524449A/en
Priority to US17/057,486 priority patent/US20220111065A1/en
Priority to PCT/EP2019/063262 priority patent/WO2019224275A1/en
Priority to SG11202010469QA priority patent/SG11202010469QA/en
Priority to KR1020207037115A priority patent/KR20210016562A/en
Priority to AU2019272838A priority patent/AU2019272838A1/en
Priority to MX2020012418A priority patent/MX2020012418A/en
Priority to BR112020023846-5A priority patent/BR112020023846A2/en
Priority to IL278819A priority patent/IL278819A/en
Priority to PH12020500670A priority patent/PH12020500670A1/en
Ceased legal-status Critical Current

Links

GBGB1818152.9A 2018-05-23 2018-11-07 Molecular adjuvant Ceased GB201818152D0 (en)

Priority Applications (15)

Application Number Priority Date Filing Date Title
GBGB1818152.9A GB201818152D0 (en) 2018-11-07 2018-11-07 Molecular adjuvant
BR112020023846-5A BR112020023846A2 (en) 2018-05-23 2019-05-22 MOLECULAR ADJUVANT
US17/057,486 US20220111065A1 (en) 2018-05-23 2019-05-22 Molecular adjuvant
SG11202010469QA SG11202010469QA (en) 2018-05-23 2019-05-22 Molecular adjuvant
EA202092296A EA202092296A1 (en) 2018-11-07 2019-05-22 MOLECULAR ADJUVANT
CN201980034789.3A CN113286616A (en) 2018-05-23 2019-05-22 Molecular adjuvant
JP2020564541A JP2021524449A (en) 2018-05-23 2019-05-22 Molecular adjuvant
EP19729452.3A EP3796942A1 (en) 2018-05-23 2019-05-22 Molecular adjuvant
PCT/EP2019/063262 WO2019224275A1 (en) 2018-05-23 2019-05-22 Molecular adjuvant
CA3098103A CA3098103A1 (en) 2018-05-23 2019-05-22 Molecular adjuvant
KR1020207037115A KR20210016562A (en) 2018-05-23 2019-05-22 Molecular adjuvant
AU2019272838A AU2019272838A1 (en) 2018-05-23 2019-05-22 Molecular adjuvant
MX2020012418A MX2020012418A (en) 2018-05-23 2019-05-22 Molecular adjuvant.
IL278819A IL278819A (en) 2018-05-23 2020-11-18 Molecular adjuvant
PH12020500670A PH12020500670A1 (en) 2018-05-23 2020-11-19 Molecular adjuvant

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1818152.9A GB201818152D0 (en) 2018-11-07 2018-11-07 Molecular adjuvant

Publications (1)

Publication Number Publication Date
GB201818152D0 true GB201818152D0 (en) 2018-12-19

Family

ID=64655555

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1818152.9A Ceased GB201818152D0 (en) 2018-05-23 2018-11-07 Molecular adjuvant

Country Status (2)

Country Link
EA (1) EA202092296A1 (en)
GB (1) GB201818152D0 (en)

Also Published As

Publication number Publication date
EA202092296A1 (en) 2021-05-21

Similar Documents

Publication Publication Date Title
IL278819A (en) Molecular adjuvant
GB201917181D0 (en) No details
GB201917180D0 (en) No details
GB201917178D0 (en) No details
GB202017924D0 (en) No details
GB201910775D0 (en) No Details
IL280912A (en) Novel methods
GB201918422D0 (en) No details
GB201908106D0 (en) No details
SG11202005711TA (en) Novel uses
GB202007832D0 (en) No details
IL282396A (en) Novel uses
GB201918330D0 (en) No details
GB201905867D0 (en) No details
GB202004524D0 (en) No details
GB201819453D0 (en) Molecular signature
GB201811382D0 (en) Vaccine
GB201818152D0 (en) Molecular adjuvant
GB201813067D0 (en) Molecular adjuvant
HK40039229A (en) Molecular adjuvant
GB201912486D0 (en) No details
GB201904663D0 (en) No details
GB201816343D0 (en) Disclosure
GB201816327D0 (en) Disclosure
GB201913500D0 (en) No details

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)